NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=151763&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151765&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cable One, Inc. ("Cable One, Inc.") (NYSE:CABO) concerning possible violations of federal securities laws. On May 2, 2025, Cable One missed earnings expectations by nearly $8 and suspended its dividend.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/urogen-pharma-ltd-lawsuit-submission-form?prid=151764&wire=1&utm_campaign=27 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Red Cat Holdings, Inc. (NASDAQ:RCAT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/red-cat-holdings-inc-lawsuit-submission-form?prid=151760&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151766&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your NET Power, Inc. (NYSE:NPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/net-power-inc-lawsuit-submission-form?prid=151759&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Bitfarms Ltd. (NASDAQ:BITF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bitfarms-ltd-lawsuit-submission-form?prid=151767&wire=1&utm_campaign=14 or contact Joseph E.

WALTHAM, Mass.--(BUSINESS WIRE)--Dynatrace (NYSE: DT), the leading AI-powered observability platform, is accelerating the generational shift in enterprise software development by extending the Dynatrace platform with agentic AI capabilities. Designed to predict and prevent disruptions, protect systems and data, and optimize operations autonomously, these advancements mark a new era of productivity and agility, fundamentally redefining how businesses manage digital transformation. Enterprise org.

WALTHAM, Mass.--(BUSINESS WIRE)--Dynatrace (NYSE: DT), the leading AI-powered observability platform, is accelerating the generational shift in enterprise software development by extending the Dynatrace platform with agentic AI capabilities. Designed to predict and prevent disruptions, protect systems and data, and optimize operations autonomously, these advancements mark a new era of productivity and agility, fundamentally redefining how businesses manage digital transformation. Enterprise org.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of NeuroPace, Inc. ("NeuroPace, Inc.") (NASDAQ:NPCE) concerning possible violations of federal securities laws. NeuroPace issued a press release on May 27, 2025, "announc[ing] the preliminary primary endpoint one-year results of the two-year NAUTILUS study evaluating safety and effectiveness of the RNS System for treatment of individuals with drug-resistant idiopathic generalized epilepsy (IGE).

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=151770&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Rocket Pharmaceuticals, Inc. ("Rocket Pharmaceuticals, Inc.") (NASDAQ:RCKT) concerning possible violations of federal securities laws. Rocket issued a press release on May 27, 2025, "announc[ing] an update related to RP-A501, its investigational gene therapy for Danon disease.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151775&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Rocket Companies, Inc. (NYSE:RKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://www.zlk.com/pslra-1/rocket-companies-inc-loss-submission-form?prid=151768&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=151772&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=151773&wire=1&utm_campaign=11 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151769&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 5, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=151774&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

MINNEAPOLIS--(BUSINESS WIRE)--Ameriprise Financial, Inc. (NYSE: AMP) today announced that it received high recognition in the 2025 Kiplinger Readers' Choice Awards. Kiplinger, a publication known for personal finance advice and news, invited their readers to rate the financial firms they affiliate with on key dimensions of the client experience. Ameriprise was one of only two firms to earn an “outstanding” accolade in all four categories surveyed: Trustworthiness of financial advisors Quality o.